Abstract:Background In the context of rapid economic and social development, there has been a continuous intensification of population aging, transformation of disease patterns, and wide application of new medical technologies. As a result, health expenditures in various countries have sharply soared. How to utilize limited medical resources to maximize the improvement of health levels has become a hot and challenging issue related to the well-being of all humanity. The relevant indicators of total health expenditure play a crucial role in monitoring and evaluating the fairness of health financing and health security in the region. Objective This study explores the changes in the main expenses that constitute China’s total health expenditure and uses indicators related to health expenditure to observe the changes and future development trends of China’s health expenditure. Based on this, the utilization of China’s health expenditure is monitored to identify possible problems, and thereby targeted suggestions for promoting the development of China’s health and wellness cause are put forward. Methods Based on the comparison of previous literature, this paper analyzes the changes and future development trends in China’s health expenditure by using the relevant indicators of China’s health expenditure through the structural variation analysis method and the gray prediction model. Results The results show that the scale of government, social, and out-of-pocket health expenditures has continuously expanded, with social health expenditures becoming the main funding source for total health expenditures. The burden of medical expenditures on individuals has been further reduced. In the institutional method of total health expenditures, hospital expenditures account for about 60% of the total and are the main component. The expenditures of health administration and medical insurance management institutions are the main driving force behind the growth of total health expenditures. However, the proportion of health expenditures in China’s GDP is relatively low, so more investment is needed in the healthcare sector, and the burden of individual medical expenses also needs to be continuously reduced. Discussion In the future, China should further increase its investment in the medical and health sector. Specifically, the government should persist in investing in fundamental medical and health services. Simultaneously, efforts should be made to establish a scientific cost control mechanism for pharmaceuticals and broaden financing channels for healthcare, such as accelerating the development of commercial health insurance.

Corrigendum: Analysis of the structure and trend prediction of China's total health expenditure

Analysis of the structure and trend prediction of China’s total health expenditure

Correction: Comparing Maternal Services Utilization and Expense Reimbursement Before and after the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China

Corrigendum: A comparative study for accessing primary healthcare between planning assessment and actual utilization for older adults: a case from Dalian City, China

Corrigendum: Unmet healthcare needs predict frailty onset in the middle-aged and older population in China: A prospective cohort analysis

Corrigendum to "trend of HIV-1 Drug Resistance in China: A Systematic Review and Meta-Analysis of Data Accumulated over 17 Years (2001-2017)" [eclinicalmedicine 18 (2020) 100238].

Corrigendum: Delayed Diagnosis and Treatment of Cancer Patients During the COVID-19 Pandemic in Henan, China: an Interrupted Time Series Analysis

Erratum: Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

Corrigendum to "Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort study" [The Lancet Regional Health - Western Pacific 44 (2024) 100984].

An application of ARIMA model for predicting total health expenditure in China from 1978-2022

Correction: Hong Kong Hospital Authority resource efficiency evaluation: Via a novel DEA-Malmquist model and Tobit regression model

Corrigendum: Regional disparities in the prevalence and correlated factors of myopia in children and adolescents in Gansu, China

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Extreme Risk Spillover between Chinese Stock Market and International Stock Markets:Notation Misprint Corrections

Corrigendum: Non-biological factors associated with postpartum depression among women in Shenzhen: a case-control study

Corrigendum to "Digital exclusion and functional dependence in older people: findings from five longitudinal cohort studies" eClinical Medicine 54 (2022) 101708

Corrigendum: An evaluation of outpatient satisfaction based on the national standard questionnaire: a satisfaction survey conducted in a tertiary hospital in Shenyang, China

Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

Corrigendum to "Counterfactual analysis of the 2023 Omicron XBB wave in China" [Infect. Dis. Model. 9 (2024) 195-203].

Corrigendum: Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020–2021: Impact on medication adherence

Retracted: Influence of Degree of Chinese Cultural Identity and Performance Expectation on Consumption Attitude for Health Care of Traditional Chinese Medicine